The primary goal of the studies proposed is a better understanding of bone resorption, to be achieved by isolating the specific precursor to the osteoclast, and by demonstrating the differentiation of the isolated progenitor cells into functional osteoclasts. After the precursor of the osteoclast has been isolated, then the proliferation, migration/recruitment to bone, and differentiation of this cell can be studied, both under normal conditions, and in osteolytic disease states such as osteoporosis and periodontal disease. This could lead to the clinical management of osteoclastic populations and their functions. Osteoclasts are formed by the fusion of mononuclear precursors which originate extraskeletally. Recent evidence indicates that they are derived fom hemopoietic stem cells. Osteoclastic precursors will be identified by isolating various progenitor pools from normal bone marrow, using monoclonal antibodies to specific surface antigens (Thy 1.1) and fluorescence-activated cell sorting. The various precursor cell pools will be evaluated for their ability to differentiate into osteoclasts and resorb bone by three assay systems: 1) Precursor cells isolated from normal rat bone marrow will be tested for their ability to differentiate into functional osteoclasts in vivo, by transplanting them into inbred ia osteopetrotic recipient rats. The value of this system is that osteoclasts of donor origin can be morphologically distinguished from mutant cells. The cellular pools will be tested for their ability to cure the skeletal sclerosis in the ia rats. 2) Precursor cells will be combined with devitalized bone chips in diffusion chambers. The chambers will be implanted into recipient rats to test the ability of the progenitor cells to differentiate into osteoclasts and resorb bone in response to different bone substrates, but in the absence of other bone cells. 3) Progenitor cells will be co-cultured with fetal long bones in vitro to determine if the interaction of the progenitor cells with the bone substrate as well as bone-forming cells is necessary to initiate the differentiation of osteoclasts and bone resorption. The cumulative results of these assays should further define the precursor to the osteoclast.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE006065-05
Application #
3219779
Study Section
Oral Biology and Medicine Study Section (OBM)
Project Start
1981-08-01
Project End
1988-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Loyola University Chicago
Department
Type
Schools of Medicine
DUNS #
791277940
City
Maywood
State
IL
Country
United States
Zip Code
60153
Schneider, Gary B; Grecco, Kristina J; Safadi, Fayez F et al. (2003) The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone. Crit Rev Eukaryot Gene Expr 13:277-84
Benis, K A; Schneider, G B (1996) The effects of vitamin D binding protein-macrophage activating factor and colony-stimulating factor-1 on hematopoietic cells in normal and osteopetrotic rats. Blood 88:2898-905
Popoff, S N; Schneider, G B (1996) Animal models of osteopetrosis: the impact of recent molecular developments on novel strategies for therapeutic intervention. Mol Med Today 2:349-58
Schneider, G B; Benis, K A; Flay, N W et al. (1995) Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 16:657-62
Schneider, G B; Relfson, M (1994) Effects of interleukin-2 on bone resorption and natural immunity in osteopetrotic (ia) rats. Lymphokine Cytokine Res 13:335-41
Schneider, G B; Relfson, M; Langman, C B (1994) Effects of 1,25-dihydroxyvitamin D3 on bone resorption and natural immunity in osteopetrotic (ia) rats. J Bone Miner Res 9:585-91
Schneider, G B; Relfson, M; Ellis, T M (1992) Qualitative defects in natural killer cell function in ia osteopetrotic rats. J Bone Miner Res 7:941-9
Schneider, G B; Relfson, M (1989) Pluripotent hemopoietic stem cells give rise to osteoclasts in vitro: effects of rGM-CSF. Bone Miner 5:129-38
Schneider, G B; Relfson, M (1988) The effects of transplantation of granulocyte-macrophage progenitors on bone resorption in osteopetrotic rats. J Bone Miner Res 3:225-32
Schneider, G B; Relfson, M (1988) A bone marrow fraction enriched for granulocyte-macrophage progenitors gives rise to osteoclasts in vitro. Bone 9:303-8

Showing the most recent 10 out of 17 publications